MANUEL MARQUEZ: Open Payments
NPI 1740532977 · FAIRFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$959 in 61 payments from 10 companies in 2025. Trend: 2023 $922 · 2024 $1,164 · 2025 $959
Food & beverage: $959
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 27 | $329 |
| SCILEX PHARMACEUTICALS INC. | 14 | $252 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $140 |
| PFIZER INC. | 3 | $56 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $43 |
| ABBVIE INC. | 2 | $42 |
| TerSera Therapeutics LLC | 1 | $31 |
| Averitas Pharma Inc. | 1 | $27 |
| Tonix Medicines, Inc. | 1 | $21 |
| Abbott Laboratories | 1 | $18 |
Products named: Belbuca, ZTLido, RELISTOR, ELYXYB - CELECOXIB, QULIPTA, NURTEC ODT, Prialt, JOURNAVX.
Industry payments across CT — which companies pay providers there.
